(Q44022873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

meta-analysis

0 references

title

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

5

John Zalcberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Val Gebski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bryan Burmeister

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kerwyn Foo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

John Simes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Australasian Gastro-Intestinal Trials Group

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

226-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

Multidisciplinary approach to esophageal and gastric cancer

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Esophageal cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Preoperative radiotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Models for estimating the number of unpublished studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Induction chemotherapy in the treatment of patients with carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970039-6

7 January 2021

10.1016/S1470-2045(07)70039-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329193%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference